Neurodegeneration and the Heat Shock Protein 70 Machinery: Implications for Therapeutic Development

Author(s): Sarah N. Fontaine, Mackenzie D. Martin, Chad A. Dickey

Journal Name: Current Topics in Medicinal Chemistry

Volume 16 , Issue 25 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The growing prevalence of individuals diagnosed with neurodegenerative disorders has brought into sharp relief the lack of treatment options for individuals struggling with these diseases. As more is discovered about the mechanisms of these neurodegenerative conditions, increasing evidence indicates a common theme in these proteinopathies is altered cellular protein homeostasis. In particular, the interactions of disease-associated proteins with the major cellular chaperones, heat shock proteins90 kDa and 70 kDa (Hsp90/Hsp70), are changed. Therefore, a promising strategy for therapeutic intervention is chemical inhibition and modification of these molecular chaperone proteins. Here we review the rationale behind therapeutic strategies targeting Hsp70 and its complement of co-chaperones, and describe the current literature regarding the use of small molecule inhibitors of Hsp70 in models of neurodegenerative disease.

Keywords: Alzheimer’s disease, Chaperone, Heat shock protein, Parkinson’s disease, Tau, Small molecule inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 13 April, 2016
Page: [2741 - 2752]
Pages: 12
DOI: 10.2174/1568026616666160413140741
Price: $65

Article Metrics

PDF: 50